DR. WILLIAM K. DECKER, PHD

DOCTOR

Dr. Decker leads our highly skilled team of researchers dedicated to applying cutting edge science to the immunotherapeutic treatment of cancer.

He holds multiple patents on innovative technologies in the field of cancer vaccination. His vaccine technologies are the focus of two phase I clinical trials for intent to treat pediatric brain tumors and adult pancreatic cancer.

Dr. Decker earned a BS in Biology from Tufts University in 1994 and a PhD in Molecular and Human Genetics from Baylor College of Medicine in 2001. He holds multiple patents on innovative technologies in the field of cancer vaccination. His vaccine technologies are the focus of two phase I clinical trials for intent to treat pediatric brain tumors and adult pancreatic cancer. Dr. Decker leads our highly skilled team of researchers dedicated to applying cutting edge science to the immunotherapeutic treatment of cancer.

INSTITUTION
Baylor College of Medicine
Pathology & Immunology
Houston, TX, US

EDUCATION
BS from Tufts University
05/1994 – Sommerville, Massachusetts, United States

PhD from Baylor College Of Medicine
02/2001 – Houston, Texas, United States

SELECTED PUBLICATIONS

ARTICLES 

  • “Discovery of CTLA-4 in dendritic cells opens new possibilities to fight cancer”  FROMTHELABSBLOG  READ NOW

DONATE NOW